by Amy Berger | Dec 10, 2024 | News, Publications and Press
Check Out Recent IITRI Mentions and Co-authored Publications Below! NPJ Vaccines Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines Published Nov 19, 2024. MDPI Vaccines Intranasal M2SR and BM2SR Vaccine...
by Amy Berger | Sep 11, 2024 | Events, News
Our team will be in Austin for the American College of Toxicology Meeting and Expo Live! this November! You can find our team in the exhibit hall at Booth 406 near the entrance. We look forward to speaking with everyone there! Drop us a line if you’d like to set up a...
by Amy Berger | Jul 24, 2024 | Blog, Events, News
MEET WITH OUR TEAM IN DC! We are excited to announce our participation in the Inaugural General Membership Meeting for the BARDA Rapid Response Partnership Vehicle (RRPV) consortium in Washington, D.C., on August 13-14. We will be presenting a poster and participating...
by Amy Berger | Jul 15, 2024 | Blog
Ferrets: The Gold Standard in Influenza Transmission Studies In preclinical research, ferrets are regarded as the premier animal model for conducting relevant influenza efficacy and transmission studies. Their susceptibility to human influenza viruses and similarity...
by Amy Berger | May 2, 2024 | Blog
In pharmaceutical and biotech development, there exists a regulatory pathway known as the Animal Rule or Animal Efficacy Rule. This pathway becomes essential when traditional human clinical trials are not feasible or ethical, often due to the nature of the...
Recent Comments